~~<i id='341269B646'><strike id='341269B646'><tt id='341269B646'><pre id='341269B646'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

focus

comprehensive

author：Wikipedia 2025-10-01 01:50:34 - browse：8879

the shape of a medical note connected by dots and lines — health tech coverage from STAT — Adobe

In recent months, the federal government has repeatedly told Medicare Advantage insurers that they cannot use artificial intelligence or algorithms to deny medical services the government routinely covers.

But in finalizing a rule to that effect, it also stepped into a thicket of questions from insurers about a technology that is especially difficult to pin down: What is AI? Can it be used at all to make decisions about the coverage of older patients? If so, how?

This week, the federal agency that oversees Medicare sought to boil it all down into a simple directive: Put the circumstances of the individual patient first, and your algorithm second.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Moonlake's readout produced a cash windfall. Risks remain
Next article： Supreme Court to hear if Covid misinformation is protected speech

leisure time

explore

focus

explore

Wikipedia

focus

FranvanDelftforGalapagosSeekingtodifferentiateitselffromothermakersofCAR-Tcancertherapies,GalapagosN

WSS

Readout LOUD podcast: Biotech layoffs, stock slump, 2024 preview

Research misconduct: Proposed new rules face resistance

Novo Nordisk testing Wegovy against alcohol

Gilead’s Trodelvy fails in lung cancer, raises questions on ADCs

HHS suspends federal funding for EcoHealth Alliance

Francis Collins on trust in science and how Covid communications failed

focus

comprehensive

leisure time

Trump demands the U.S. pay no more for drugs than other countries … again

Ripples from Flovent's discontinuation is killing children with asthma

Peter Hotez and the public health issue of online harassment

The surgeon had a dilemma only a Nazi medical text could resolve

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

EU regulator recommends expanding Mounjaro approval to obesity

United colonoscopy coverage change 'may cost lives,' doctors say

Lilly’s weekly insulin works as well as daily products, new studies show

Sports medicine is finally prioritizing gender equality

WuXi Biologics execs register to lobby as Congress comes for the company

explore

Test for long Covid? Researchers find new clue in blood samples

Gilead’s Trodelvy fails in lung cancer, raises questions on ADCs

STAT series 'Denied by AI' wins major journalism prizes

Readout Newsletter: Biogen, Ionis, Johnson & Johnson news

Why doctors need education on FDA device approval process

Copay coupons to count toward deductibles, after Biden court move

focus

explore

Wikipedia

focus